Clinical Trial Update: A Study of DZD9008 Versus Platinum-Based Doublet Chemotherapy in Local Advanced or Metastatic Non-small Cell Lung Cancer (WU-KONG28) [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing DZD9008 with platinum-based doublet chemotherapy in locally advanced or metastatic non-small cell lung cancer; the study is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• DZD9008
• Platinum-based doublet chemotherapy

Snippet

Sponsor: Dizal Pharmaceuticals | Conditions: Non-small Cell Lung Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING